{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:21:17Z","timestamp":1791231677355,"version":"4.1.0"},"reference-count":0,"publisher":"Wiley","issue":"13","license":[{"start":{"date-parts":[[1991,10,1]],"date-time":"1991-10-01T00:00:00Z","timestamp":686275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The FASEB Journal"],"published-print":{"date-parts":[[1991,10]]},"abstract":"<jats:p>\n                    Neurodegenerative diseases of animals and humans including scrapie, bovine spongiform encephalopathy, and Creutzfeldt\u2010Jakob disease are caused by unusual infectious pathogens called prions. There is no evidence for a nucleic acid in the prion, but diverse experimental results indicate that a host\u2010derived protein called PrP\n                    <jats:sup>Sc<\/jats:sup>\n                    is a component of the infectious particle. Experiments with scrapie\u2010infected cultured cells show that PrP\n                    <jats:sup>Sc<\/jats:sup>\n                    is derived from a normal cellular protein called PrP\n                    <jats:sup>C<\/jats:sup>\n                    through an unknown posttranslational process. We have analyzed the amino acid sequence and posttranslational modifications of PrP\n                    <jats:sup>Sc<\/jats:sup>\n                    and its proteolytically truncated core PrP 27\u201030 to identify potential candidate modifications that could distinguish PrP\n                    <jats:sup>Sc<\/jats:sup>\n                    from PrP\n                    <jats:sup>C<\/jats:sup>\n                    . The amino acid sequence of PrP 27\u201030 corresponds to that predicted from the gene and cDNA. Mass spectrometry of peptides derived from PrP\n                    <jats:sup>Sc<\/jats:sup>\n                    has revealed numerous modifications including two N\u2010linked carbohydrate moieties, removal of an amino\u2010terminal signal sequence, and alternative COOH termini. Most molecules contain a glycosylinositol phospholipid (GPI) attached at Ser\u2010231 that results in removal of 23 amino acids from the COOH terminus, whereas 15% of the protein molecules are truncated to end at Gly\u2010228. The structure of the GPI from PrP\n                    <jats:sup>Sc<\/jats:sup>\n                    has been analyzed and found to be novel, including the presence of sialic acid. Other experiments suggest that the N\u2010linked oligosaccharides are not necessary for PrP\n                    <jats:sup>Sc<\/jats:sup>\n                    formation. Although detailed comparison of PrP\n                    <jats:sup>Sc<\/jats:sup>\n                    with PrP\n                    <jats:sup>C<\/jats:sup>\n                    is required, there is no obvious way in which any of the modifications might confer upon prp\n                    <jats:sup>Sc<\/jats:sup>\n                    its unusual physical properties and allow it to act as a component of the prion. If no chemical difference is found between PrP\n                    <jats:sup>C<\/jats:sup>\n                    and PrP\n                    <jats:sup>Sc<\/jats:sup>\n                    , then the two isoforms of the prion protein may differ only in their conformations or by the presence of bound cellular components.\u2014Stahl, N.; Prusiner, S. B. Prions and prion proteins.\n                    <jats:italic>FASEB J.<\/jats:italic>\n                    5: 2799\u20102807; 1991.\n                  <\/jats:p>","DOI":"10.1096\/fasebj.5.13.1916104","type":"journal-article","created":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T04:41:38Z","timestamp":1516855298000},"page":"2799-2807","source":"Crossref","is-referenced-by-count":120,"title":["Prions and prion proteins\n                    <sup>1<\/sup>"],"prefix":"10.1096","volume":"5","author":[{"given":"Neil","family":"Stahl","sequence":"first","affiliation":[{"name":"Departments of Neurology and of Biochemistry and Biophysics University of California San Francisco California 94143\u20100518 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley B.","family":"Prusiner","sequence":"additional","affiliation":[{"name":"Departments of Neurology and of Biochemistry and Biophysics University of California San Francisco California 94143\u20100518 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[1991,10]]},"container-title":["The FASEB Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fasebj.5.13.1916104","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fasebj.5.13.1916104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T21:23:15Z","timestamp":1761686595000},"score":1,"resource":{"primary":{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fasebj.5.13.1916104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,10]]},"references-count":0,"journal-issue":{"issue":"13","published-print":{"date-parts":[[1991,10]]}},"alternative-id":["10.1096\/fasebj.5.13.1916104"],"URL":"https:\/\/doi.org\/10.1096\/fasebj.5.13.1916104","archive":["Portico"],"relation":{},"ISSN":["0892-6638","1530-6860"],"issn-type":[{"value":"0892-6638","type":"print"},{"value":"1530-6860","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,10]]}}}